<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335293">
  <stage>Registered</stage>
  <submitdate>23/03/2010</submitdate>
  <approvaldate>14/10/2010</approvaldate>
  <actrnumber>ACTRN12610000863033</actrnumber>
  <trial_identification>
    <studytitle>Curing Atrial Fibrillation: A Comparison of 2 Keyhole Techniques</studytitle>
    <scientifictitle>Minimal versus Maximal Radiofrequency Ablation to Achieve Enduring freedom from Atrial Fibrillation</scientifictitle>
    <utrn>U1111-1114-5079</utrn>
    <trialacronym>MINIMAX Study</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Atrial Fibrillation</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Pulmonary vein isolation by wide encircling ablation of ipsilateral veins with linear ablation of the intervenous ridge. This procedure takes 2-4 hours and involves advancing specialized catheters into the heart via a keyhole approach, and using heat energy to place strategically-positioned scars in the upper chambers of the heart to cure atrial fibrillation. It is done as a one-off procedure, though occassionally a second procedure is required.</interventions>
    <comparator>Pulmonary vein isolation by wide encircling ablation of ipsilateral veins without linear ablation of the intervenous ridge. This procedure takes 2-4 hours and involves advancing specialized catheters into the heart via a keyhole approach, and using heat energy to place strategically-positioned scars in the upper chambers of the heart to cure atrial fibrillation. It is done as a one-off procedure, though occassionally a second procedure is required.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Single procedure success at 12 months from the date of procedure defined by freedom from atrial fibrillation by symptoms and holter monitoring.</outcome>
      <timepoint>12 months from the date of procedure.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Procedural complications at 12 months from the date of procedure. Acute complications: pericaridal tamponade judged by need for pericardiocentesis, signficant groin haematoma/bleed judged by need for ultrasound imaging or blood transfusion, stroke based on clinical assessment post procedure and at follow up. Long-term complications: pulmonary vein stenosis based on follow-up CT pulmonary venography.</outcome>
      <timepoint>12 months from the date of procedure.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age 18 or greater
Paroxysmal atrial fibrillation
Failure of at least one antiarrhythmic medication
Suitable for 1st time atrial fibrillation ablation</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnancy
Contraindications to atrial fibrillation ablation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients referred for consideration of first time atrial fibrillation (AF) ablation will be screened and enrolled. Randomization into interventional arms will be determined by coin-toss on the day of the intervention.</concealment>
    <sequence>Simple randomization by coin-tossing.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Multicentre</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/05/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>150</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Cambridge</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>A/Prof Peter Kistler</primarysponsorname>
    <primarysponsoraddress>Clinical Electrophysiolog Research, Baker IDI Heart and Diabetes Institute
75 Commercial Road
Melbourne
Victoria 2004</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>Clinical Electrophysiology Research, Baker IDI Heart and Diabetes Institute</fundingname>
      <fundingaddress>75 Commercial Road
Melbourne
Victoria 2004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Alfred Hospital</sponsorname>
      <sponsoraddress>Commercial Road
Prahran
Victoria 3181</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Atrial fibrillation is a common heart rhythm disorder and is associated with heart rhythm irregularity. This trial aims to compare the relative efficacy of 2 different keyhole procedures to cure atrial fibrillation.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Alfred Human Research Ethics Committee</ethicname>
      <ethicaddress>Commercial Road
Prahran
Victoria 3181</ethicaddress>
      <ethicapprovaldate>11/03/2010</ethicapprovaldate>
      <hrec>31/10/2010</hrec>
      <ethicsubmitdate>24/02/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Liang-han Ling</name>
      <address>Clinical Electrophysiology Research
Baker IDI Heart and Diabetes Institute
75 Commerical Road
Melbourne
Victoria 3004</address>
      <phone>+61385321111</phone>
      <fax>+61385321100</fax>
      <email>han.ling@bakeridi.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Liang-han Ling</name>
      <address>Clinical Electrophysiology Research
Baker IDI Heart and Diabetes Institute
75 Commerical Road
Melbourne
Victoria 3004</address>
      <phone>+61385321111</phone>
      <fax>+61385321100</fax>
      <email>han.ling@bakeridi.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Liang-han Ling</name>
      <address>Clinical Electrophysiology Research
Baker IDI Heart and Diabetes Institute
75 Commerical Road
Melbourne
Victoria 3004</address>
      <phone>+61385321111</phone>
      <fax>+61385321100</fax>
      <email>han.ling@bakeridi.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>